Novartis' Alcon eye care division has entered an in-license agreement governing all ocular medical uses for Google's smart contact lenses, it announced Tuesday. Google unveiled a prototype of its glucose-monitoring lens in January. No financial details of the arrangement were released, and the deal needs to clear regulators before it can be completed. Novartis sees its deal with Google as a way to expand its healthcare horizons. There are 382 million diabetics around the world today and that number is expected to grow to 582 million by 2035.Google, Novartis Team on 'Invisible' Health Monitor
Novartis' Alcon eye care division has entered an in-license agreement governing all ocular medical uses for Google's smart contact lenses, it announced Tuesday. Google unveiled a prototype of its glucose-monitoring lens in January. No financial details of the arrangement were released, and the deal needs to clear regulators before it can be completed. Novartis sees its deal with Google as a way to expand its healthcare horizons. There are 382 million diabetics around the world today and that number is expected to grow to 582 million by 2035.
0 comments:
Post a Comment